aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet [Norgesic]
RxNorm concept 994530, branded drug (sbd). Prescribable name: Norgesic 25 MG / 385 MG / 30 MG Oral Tablet.
- RxCUI
- 994530
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/994530 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ASA 385 MG / Caffeine 30 MG / Orphenadrine Citrate 25 MG Oral Tablet [Norgesic]; Norgesic 25/385/30 (orphenadrine / aspirin / caffeine) Oral Tablet
Related concepts
- caffeine 30 MG (SCDC, consists of)
- aspirin 385 MG (SCDC, consists of)
- orphenadrine citrate 25 MG (SCDC, consists of)
- aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG [Norgesic] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Norgesic (BN, has ingredient)
- aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 994530 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/994530 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 994530. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.